Literature DB >> 8240296

Post-translational processing of progastrin: inhibition of cleavage, phosphorylation and sulphation by brefeldin A.

A Varro1, G J Dockray.   

Abstract

The precursor for the acid-stimulating hormone gastrin provides a useful model for studies of post-translational processing because defined sites of cleavage, amidation, sulphation and phosphorylation occur within a dodecapeptide sequence. The factors determining these post-translational processing events are still poorly understood. We have used brefeldin A, which disrupts transport from rough endoplasmic reticulum to the Golgi complex, to examine the mechanisms of cleavage, phosphorylation and sulphation of rat progastrin-derived peptides. Biosynthetic products were detected after immunoprecipitation using antibodies specific for the extreme C-terminus of progastrin, followed by reversed-phase and ion-exchange h.p.l.c. Gastrin cells incorporated [3H]tyrosine, [32P]phosphate and [35S]sulphate into both progastrin and its extreme C-terminal tryptic (nona-) peptide. Ion-exchange chromatography resolved four forms of the C-terminal tryptic fragment of progastrin which differed in whether they were phosphorylated at Ser96, sulphated at Tyr103, both or neither. The specific activity of [3H]tyrosine in the peak that was both phosphorylated and sulphated was higher than in the others. Brefeldin A inhibited the appearance of [3H]tyrosine-labelled C-terminal tryptic fragment but there was an accumulation of labelled progastrin and a peptide corresponding to the C-terminal 46 residues of progastrin. Brefeldin A also inhibited incorporation of 32P and 35S into both progastrin and its C-terminal fragment. Thus phosphorylation of Ser96, sulphation of Tyr103 and cleavage at Arg94-Arg95 depend on passage of newly synthesized progastrin along the secretory pathway; as brefeldin A is thought to act proximal to the trans-Golgi, these processing steps would appear to occur distal to this point. The data also indicate that the stores of unphosphorylated C-terminal tryptic fragment are not available for phosphorylation, implying that this modification occurs proximal to the secretory granule; cleavage is known to occur in the secretory granule which suggests that it occurs after phosphorylation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240296      PMCID: PMC1134634          DOI: 10.1042/bj2950813

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

1.  Novel blockade by brefeldin A of intracellular transport of secretory proteins in cultured rat hepatocytes.

Authors:  Y Misumi; Y Misumi; K Miki; A Takatsuki; G Tamura; Y Ikehara
Journal:  J Biol Chem       Date:  1986-08-25       Impact factor: 5.157

2.  Blockade by brefeldin A of intracellular transport of secretory proteins in mouse pituitary cells: effects on the biosynthesis of thyrotropin and free alpha-subunits.

Authors:  J A Magner; E Papagiannes
Journal:  Endocrinology       Date:  1988-03       Impact factor: 4.736

3.  Biosynthesis of gastrin. Localization of the precursor and peptide products using electron microscopic-immunogold methods.

Authors:  J Rahier; S Pauwels; G J Dockray
Journal:  Gastroenterology       Date:  1987-05       Impact factor: 22.682

Review 4.  Post-translational proteolysis in polypeptide hormone biosynthesis.

Authors:  K Docherty; D F Steiner
Journal:  Annu Rev Physiol       Date:  1982       Impact factor: 19.318

5.  Biosynthesis of the vitellogenins. Identification and characterization of nonphosphorylated precursors to avian vitellogenin I and vitellogenin II.

Authors:  S Y Wang; D L Williams
Journal:  J Biol Chem       Date:  1982-04-10       Impact factor: 5.157

6.  Reversal by omeprazole of the depression of gastrin cell function by fasting in the rat.

Authors:  R Dimaline; D Evans; A Varro; G J Dockray
Journal:  J Physiol       Date:  1991-02       Impact factor: 5.182

7.  Isolation and characterization of the intact gastrin precursor from a gastrinoma.

Authors:  H Desmond; S Pauwels; A Varro; H Gregory; J Young; G J Dockray
Journal:  FEBS Lett       Date:  1987-01-05       Impact factor: 4.124

8.  Post-translational processing of the porcine gastrin precursor by phosphorylation of the COOH-terminal fragment.

Authors:  G J Dockray; A Varro; H Desmond; J Young; H Gregory; R A Gregory
Journal:  J Biol Chem       Date:  1987-06-25       Impact factor: 5.157

9.  Casein kinase activity in rat mammary gland Golgi vesicles. Demonstration of latency and requirement for a transmembrane ATP carrier.

Authors:  D W West; R A Clegg
Journal:  Biochem J       Date:  1984-04-01       Impact factor: 3.857

10.  Biosynthesis of tyrosine O-sulfated gastrins in rat antral mucosa.

Authors:  S J Brand; J Klarlund; T W Schwartz; J F Rehfeld
Journal:  J Biol Chem       Date:  1984-11-10       Impact factor: 5.157

View more
  6 in total

Review 1.  Topical review. Gastrin and gastric epithelial physiology.

Authors:  G J Dockray
Journal:  J Physiol       Date:  1999-07-15       Impact factor: 5.182

2.  Purification of Golgi casein kinase from bovine milk.

Authors:  J S Duncan; M C Wilkinson; R D Burgoyne
Journal:  Biochem J       Date:  2000-09-01       Impact factor: 3.857

3.  Characterization of the effects of Ca2+ depletion on the synthesis, phosphorylation and secretion of caseins in lactating mammary epithelial cells.

Authors:  J S Duncan; R D Burgoyne
Journal:  Biochem J       Date:  1996-07-15       Impact factor: 3.857

4.  Modulation of gastrin processing by vesicular monoamine transporter type 1 (VMAT1) in rat gastrin cells.

Authors:  I Hussain; G W Bate; J Henry; P Djali; R Dimaline; G J Dockray; A Varro
Journal:  J Physiol       Date:  1999-06-01       Impact factor: 5.182

5.  Pathways of processing of the gastrin precursor in rat antral mucosa.

Authors:  A Varro; S Voronina; G J Dockray
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

6.  G and D cells in rat antral mucosa: an immunoelectron microscopic study.

Authors:  Feng-Peng Sun; Yu-Gang Song
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.